Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple TherapyYvon Lebranchu, Gérard Rifle, Frank Bridoux et al.|American Journal of Transplantation|2002Cited by 256
Early Low‐Grade Proteinuria: Causes, Short‐Term Evolution and Long‐Term Consequences in Renal TransplantationJean‐Michel Halimi, Yvon Lebranchu, I. Laouad et al.|American Journal of Transplantation|2005Cited by 146
Respective Predictive Role of Urinary Albumin Excretion and Nonalbumin Proteinuria on Graft Loss and Death in Renal Transplant RecipientsJean‐Michel Halimi, Yvon Lebranchu, Matthias Büchler et al.|American Journal of Transplantation|2007Cited by 84
TRANSPLANT RENAL ARTERY STENOSIS: POTENTIAL ROLE OF ISCHEMIA/REPERFUSION INJURY AND LONG-TERM OUTCOME FOLLOWING ANGIOPLASTYJean‐Michel Halimi, Yvon Lebranchu, Azmi Al-Najjar et al.|The Journal of Urology|1999Cited by 76
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantationMélanie Roland, Jean‐Michel Halimi, Philippe Gatault et al.|Transplant International|2008Cited by 63